ctDNA-Guided Therapy in Stage II Colon Cancer | NEJM
4 Views
administrator
07/07/23
The benefit of adjuvant chemotherapy for stage II colon cancer is unclear. Measuring circulating tumor DNA after surgery might offer guidance as to whether a patient will benefit. New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/3x0jR94
-
Category
Show more
Facebook Comments
No comments found